(G) Genpact - Ratings and Ratios
Outsourcing, Analytics, Consulting, Automation, Finance
G EPS (Earnings per Share)
G Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.8% |
| Value at Risk 5%th | 38.7% |
| Relative Tail Risk | -15.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -12.62 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.669 |
| Beta | 0.619 |
| Beta Downside | 0.653 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.61% |
| Mean DD | 18.42% |
| Median DD | 20.86% |
Description: G Genpact November 03, 2025
Genpact Limited (NYSE:G) is a global provider of business-process outsourcing (BPO) and information-technology services, operating across North America, Latin America, Europe, India and the rest of Asia. The firm is organized into three verticals-Financial Services; Consumer & Healthcare; and High-Tech & Manufacturing-each delivering end-to-end solutions ranging from loan processing and compliance in finance to revenue-cycle management in health care and supply-chain engineering for manufacturers.
Based on FY 2023 results (the latest publicly disclosed figures), Genpact generated roughly **$4.0 billion** in revenue, with an **operating margin of ~12%** and a **year-over-year revenue growth of 12%** driven largely by digital-transformation contracts. The company’s **backlog**-the value of signed but un-delivered work-stood at about **$8 billion**, indicating a multi-year revenue runway. Client concentration remains modest, with the top 10 customers contributing less than **10%** of total revenue, which mitigates single-client risk.
Key macro-economic drivers for Genpact include the accelerating **outsourcing spend in regulated sectors** (especially financial services) as firms seek to meet expanding compliance burdens, and the broader **adoption of AI-enabled automation** that fuels demand for data-tech and CFO advisory services. Additionally, near-shoring trends in North America are prompting enterprises to shift non-core functions to specialized providers like Genpact, supporting a secular growth tail.
For a deeper, data-driven valuation framework, you might explore the detailed metrics on ValueRay.
G Stock Overview
| Market Cap in USD | 7,670m |
| Sub-Industry | Data Processing & Outsourced Services |
| IPO / Inception | 2007-08-02 |
| Return 12m vs S&P 500 | -11.9% |
| Analyst Rating | 3.91 of 5 |
G Dividends
| Dividend Yield | 1.86% |
| Yield on Cost 5y | 2.19% |
| Yield CAGR 5y | 11.78% |
| Payout Consistency | 56.9% |
| Payout Ratio | 18.9% |
G Growth Ratios
| CAGR 3y | 2.74% |
| CAGR/Max DD Calmar Ratio | 0.08 |
| CAGR/Mean DD Pain Ratio | 0.15 |
| Current Volume | 1440.9k |
| Average Volume | 2088.9k |
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income (551.3m TTM) > 0 and > 6% of Revenue (6% = 300.6m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 2.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.99% (prev 23.71%; Δ -8.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 729.4m > Net Income 551.3m (YES >=105%, WARN >=100%) |
| Net Debt (668.0m) to EBITDA (876.9m) ratio: 0.76 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (176.1m) change vs 12m ago -2.63% (target <= -2.0% for YES) |
| Gross Margin 35.82% (prev 35.41%; Δ 0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 93.72% (prev 87.59%; Δ 6.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.32 (EBITDA TTM 876.9m / Interest Expense TTM 69.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.94
| (A) 0.14 = (Total Current Assets 2.21b - Total Current Liabilities 1.46b) / Total Assets 5.36b |
| (B) 0.26 = Retained Earnings (Balance) 1.37b / Total Assets 5.36b |
| (C) 0.15 = EBIT TTM 782.5m / Avg Total Assets 5.34b |
| (D) 0.20 = Book Value of Equity 552.8m / Total Liabilities 2.82b |
| Total Rating: 2.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 90.79
| 1. Piotroski 9.50pt = 4.50 |
| 2. FCF Yield 7.74% = 3.87 |
| 3. FCF Margin 12.89% = 3.22 |
| 4. Debt/Equity 0.55 = 2.35 |
| 5. Debt/Ebitda 0.76 = 2.07 |
| 6. ROIC - WACC (= 9.08)% = 11.35 |
| 7. RoE 22.11% = 1.84 |
| 8. Rev. Trend 96.31% = 7.22 |
| 9. EPS Trend 87.31% = 4.37 |
What is the price of G shares?
Over the past week, the price has changed by +0.90%, over one month by +12.62%, over three months by +3.13% and over the past year by +1.01%.
Is Genpact a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of G is around 41.44 USD . This means that G is currently overvalued and has a potential downside of -7.69%.
Is G a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the G price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.2 | 11.8% |
| Analysts Target Price | 50.2 | 11.8% |
| ValueRay Target Price | 45.6 | 1.7% |
G Fundamental Data Overview November 11, 2025
P/E Trailing = 14.3516
P/E Forward = 18.315
P/S = 1.5312
P/B = 2.7893
P/EG = 1.7
Beta = 0.776
Revenue TTM = 5.01b USD
EBIT TTM = 782.5m USD
EBITDA TTM = 876.9m USD
Long Term Debt = 1.20b USD (from longTermDebt, last fiscal year)
Short Term Debt = 427.3m USD (from shortTermDebt, last quarter)
Debt = 1.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 668.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.34b USD (7.67b + Debt 1.41b - CCE 740.8m)
Interest Coverage Ratio = 11.32 (Ebit TTM 782.5m / Interest Expense TTM 69.1m)
FCF Yield = 7.74% (FCF TTM 645.5m / Enterprise Value 8.34b)
FCF Margin = 12.89% (FCF TTM 645.5m / Revenue TTM 5.01b)
Net Margin = 11.01% (Net Income TTM 551.3m / Revenue TTM 5.01b)
Gross Margin = 35.82% ((Revenue TTM 5.01b - Cost of Revenue TTM 3.21b) / Revenue TTM)
Gross Margin QoQ = 36.37% (prev 35.88%)
Tobins Q-Ratio = 1.55 (Enterprise Value 8.34b / Total Assets 5.36b)
Interest Expense / Debt = 0.91% (Interest Expense 12.8m / Debt 1.41b)
Taxrate = 22.98% (43.5m / 189.4m)
NOPAT = 602.6m (EBIT 782.5m * (1 - 22.98%))
Current Ratio = 1.51 (Total Current Assets 2.21b / Total Current Liabilities 1.46b)
Debt / Equity = 0.55 (Debt 1.41b / totalStockholderEquity, last quarter 2.54b)
Debt / EBITDA = 0.76 (Net Debt 668.0m / EBITDA 876.9m)
Debt / FCF = 1.03 (Net Debt 668.0m / FCF TTM 645.5m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.28% (Net Income 551.3m / Total Assets 5.36b)
RoE = 22.11% (Net Income TTM 551.3m / Total Stockholder Equity 2.49b)
RoCE = 21.21% (EBIT 782.5m / Capital Employed (Equity 2.49b + L.T.Debt 1.20b))
RoIC = 16.20% (NOPAT 602.6m / Invested Capital 3.72b)
WACC = 7.12% (E(7.67b)/V(9.08b) * Re(8.30%) + D(1.41b)/V(9.08b) * Rd(0.91%) * (1-Tc(0.23)))
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.00%
[DCF Debug] Terminal Value 79.04% ; FCFE base≈596.1m ; Y1≈670.5m ; Y5≈899.8m
Fair Price DCF = 86.13 (DCF Value 14.85b / Shares Outstanding 172.4m; 5y FCF grow 14.47% → 3.0% )
EPS Correlation: 87.31 | EPS CAGR: 12.59% | SUE: 3.02 | # QB: 5
Revenue Correlation: 96.31 | Revenue CAGR: 5.91% | SUE: 1.17 | # QB: 2
Additional Sources for G Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle